Compounds > 2-acetylaminofluorene
Page last updated: 2024-11-07

2-acetylaminofluorene and Hypertrophy

2-acetylaminofluorene has been researched along with Hypertrophy in 2 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LAWS, JO1
RUDALI, G1
ROYER, R1
MABILLE, P1
Kunz, W1
Schaude, G1
Schwarz, M1
Tennekes, H1

Reviews

1 review available for 2-acetylaminofluorene and Hypertrophy

ArticleYear
Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Carcinogenesis; a comprehensive survey, 1982, Volume: 7

    Topics: 2-Acetylaminofluorene; Animals; Carcinogens; Cell Division; Cocarcinogenesis; Diethylnitrosamine; Do

1982

Other Studies

1 other study available for 2-acetylaminofluorene and Hypertrophy

ArticleYear
The early changes produced in the auditory sebaceous gland (Zymbal's gland) of the rat by 2-acetylaminofluorene.
    Cancer research, 1955, Volume: 15, Issue:3

    Topics: 2-Acetylaminofluorene; Animals; Ear, External; Fluorenes; Hyperplasia; Hypertrophy; Neoplasms; Rats;

1955